HAVCR1 and chronic kidney disease: In the present study, KIM-1 correlated with CKD stages, and a greater proportion of patients in the highest tertile of KIM-1 exhibited progression of CKD (57.8 vs 37% in the lowest tertile, P=0.047), providing further evidence of the utility of KIM-1 as a biomarker of progressive chronic kidney damage.